Assignee
SINGH SHARAT
US·7 granted patents·6 pending applications·103 citations·filing 2003–2012
Top patents by PatentIndex Score
13 records- 0197US8163499B2Drug selection for breast cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2009·Granted Apr 24, 2012·53 cites·88 claims
- 0294US8609349B2Drug selection for breast cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2012·Granted Dec 17, 2013·12 cites·42 claims
- 0393US8574855B2Assays for the detection of anti-TNF drugs and autoantibodiesSINGH SHARAT·Filed 2012·Granted Nov 5, 2013·21 cites·20 claims
- 0489US9110075B2Compositions for analyzing proteinsSINGH SHARAT·Filed 2011·Granted Aug 18, 2015·6 cites·12 claims
- 0585US9250243B2Drug selection for lung cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2008·Granted Feb 2, 2016·8 cites·48 claims
- 0676US8278057B2Addressable antibody arrays and methods of useSINGH SHARAT·Filed 2009·Granted Oct 2, 2012·3 cites·19 claims
- 0761US2004265858A1Sets of generalized target-binding e-tag probesSINGH SHARAT·Filed 2004·Application pending·0 cites
- 0851US2009081711A1Addressable antibody arrays and methods of useSINGH SHARAT·Filed 2008·Application pending·0 cites
- 0947US2008076139A1Methods and compositions for detecting the activation states of multiple signal transducers in rare circulating cellsSINGH SHARAT·Filed 2006·Application pending·0 cites
- 1045US2006166282A1Methods and compositions for screening cell binding moleculesSINGH SHARAT·Filed 2003·Application pending·0 cites
- 1143US2012277109A1Proximity-mediated assays for detecting oncogenic fusion proteinsSINGH SHARAT·Filed 2012·Application pending·0 cites
- 1242US2012270745A1Drug selection for cancer therapy by profiling signal transduction proteins in ascites or pleural efflux samplesSINGH SHARAT·Filed 2012·Application pending·0 cites
- 1340US10473640B2Drug selection for gastric cancer therapy using antibody-based arraysSINGH SHARAT·Filed 2011·Granted Nov 12, 2019·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →